右美托咪定延长全膝关节置换术后关节周围浸润镇痛的镇痛效果:一项前瞻性、双盲、随机对照试验
该前瞻性双盲随机对照试验将116例全膝关节置换术患者分为罗哌卡因组、罗哌卡因加肾上腺素组和罗哌卡因加右美托咪定组,发现右美托咪定组术后6小时静息视觉模拟评分显著低于其他两组,且右美托咪定或肾上腺素均推迟首次补救镇痛时间并减少术后24小时内阿片类药物用量,不增加不良事件风险。
要点
- 右美托咪定组术后6小时静息VAS评分显著低于罗哌卡因组和肾上腺素组。
- 右美托咪定或肾上腺素均推迟首次补救镇痛时间并降低术后24小时阿片用量。
- 三组功能恢复、术后并发症及不良事件无显著差异。
核心结论
- 在关节周围浸润镇痛中加入右美托咪定作为佐剂可增强并延长全膝关节置换术后早期的镇痛效果,且不增加不良事件风险。
研究设计与样本
- 前瞻性、双盲、随机对照试验,纳入116例患者,随机分为罗哌卡因组(R组)、罗哌卡因加肾上腺素组(E组)和罗哌卡因加右美托咪定组(D组)。
主要发现
- D组术后6小时静息视觉模拟评分显著低于R组和E组。
- R组术后12小时静息和运动疼痛评分高于D组和E组。
- 使用右美托咪定或肾上腺素推迟了首次补救镇痛给药时间,并降低了全膝关节置换术后24小时内的阿片类药物用量。
- D组和E组术后第3天白介素-8和肿瘤坏死因子-α水平显著低于R组。
- 三组在功能恢复、术后并发症或不良事件方面无显著差异。
临床怎么用
- 作者认为,在关节周围浸润镇痛中加入右美托咪定作为佐剂可增强并延长全膝关节置换术后早期的镇痛效果,且不增加不良事件风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periarticular infiltration analgesia (PIA) is widely administered to relieve postoperative pain following total knee arthroplasty (TKA). The present study aimed to evaluate the effect of prolonging the analgesic duration by adding dexmedetomidine to PIA for pain management after TKA. METHODS: One hundred and sixteen patients were randomly allocated into 3 groups based on PIA regimens including group R (ropivacaine), group E (ropivacaine plus epinephrine), and group D (ropivacaine plus dexmedetomidine). The primary outcomes were postoperative visual analog scale scores, time until the administration of first rescue analgesia, and opioid consumption. The secondary outcomes included postoperative inflammatory biomarkers and functional recovery. The tertiary outcomes were postoperative complications and adverse events. RESULTS: The patients in group D had significantly lower resting visual analog scale scores than those in groups R and E at 6 hours after surgery. Group R showed the higher pain scores at rest and motion than groups D and E 12 hours postoperatively. The use of dexmedetomidine or epinephrine postponed the time until the administration of first rescue analgesia and led to lower opioid consumption in the first 24 hours after TKA. The levels of interleukin-8 and tumor necrosis factor-α in groups D and E were significantly lower than those in group R on postoperative day 3. Furthermore, no significant differences were observed in functional recovery, postoperative complications, or adverse events among the three groups. CONCLUSIONS: Adding dexmedetomidine as an adjuvant to PIA could potentiate and prolong the analgesic effect in the early stage following TKA without increasing the risk of adverse events.
引用
- Zhao E, Zhou K, Liu Z, et al. Dexmedetomidine Prolongs the Analgesic Effects of Periarticular Infiltration Analgesia following Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Trial. J Arthroplasty. 2023. PMID: 36709881. doi:10.1016/j.arth.2023.01.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。